Dow Up0.59% Nasdaq Up0.39%

Enzo Biochem Inc. (ENZ)

-NYSE
4.94 Up 0.01(0.20%) 2:33PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJul 31, 2014Apr 30, 2014Jan 31, 2014Oct 31, 2013
Total Revenue 24,907   23,979   22,927   24,134  
Cost of Revenue13,972  13,583  13,158  13,555  
Gross Profit 10,935   10,396   9,769   10,579  
Operating Expenses
Research Development643  849  832  817  
Selling General and Administrative10,584  10,605  10,083  10,529  
Non Recurring2,761  (505)2,408  2,253  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,053) (553) (3,554) (3,020)
Income from Continuing Operations
Total Other Income/Expenses Net(62)152  35  358  
Earnings Before Interest And Taxes(3,162)(448)(3,571)(2,724)
Interest Expense -   -   -   -  
Income Before Tax(3,162)(448)(3,571)(2,724)
Income Tax Expense7  7  (5)63  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,169)(455)(3,566)(2,787)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,169) (455) (3,566) (2,787)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,169) (455) (3,566) (2,787)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.